Vir Biotechnology Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 05/13/2026 | 18.00 M | $161.27 M | 10.22% | 12.93% |
| ARCH VENTURE MANAGEMENT, LLC | 05/15/2026 | 12.92 M | $115.73 M | 0.00% | 9.28% |
| SB INVESTMENT ADVISERS (UK) LTD | 05/18/2026 | 10.95 M | $98.09 M | -16.53% | 7.86% |
| 05/08/2026 | 9.22 M | $82.57 M | 100.00% | 6.62% | |
| GSK PLC | 05/14/2026 | 8.55 M | $76.62 M | 0.00% | 6.14% |
| STATE STREET CORP | 05/15/2026 | 7.14 M | $63.98 M | 14.63% | 5.13% |
| 05/15/2026 | 5.38 M | $48.22 M | 100.00% | 3.87% | |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 3.25 M | $29.12 M | 107.17% | 2.33% |
| MORGAN STANLEY | 05/15/2026 | 2.85 M | $25.57 M | 6.53% | 2.05% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/18/2026 | 2.74 M | $24.59 M | 100.00% | 1.97% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 2.66 M | $23.82 M | 14.16% | 1.91% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 2.58 M | $23.11 M | 1.71% | 1.85% |
| CITADEL ADVISORS LLC | 05/15/2026 | 2.10 M | $18.80 M | 328.94% | 1.51% |
| FMR LLC | 05/15/2026 | 2.07 M | $18.56 M | -34.40% | 1.49% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 05/14/2026 | 2.00 M | $17.94 M | 100.00% | 1.44% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 1.95 M | $17.49 M | 897.47% | 1.40% |
| BOXER CAPITAL MANAGEMENT, LLC | 05/15/2026 | 1.87 M | $16.72 M | 198.56% | 1.34% |
| 05/15/2026 | 1.52 M | $13.61 M | 63.23% | 1.09% | |
| SIO CAPITAL MANAGEMENT, LLC | 05/14/2026 | 1.50 M | $13.43 M | 213.29% | 1.08% |
| PICTET ASSET MANAGEMENT HOLDING SA | 04/22/2026 | 1.48 M | $13.27 M | 10,878.86% | 1.06% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 05/13/2026 | 1.47 M | $13.17 M | 10.91% | 1.06% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 05/15/2026 | 1.44 M | $12.92 M | 100.00% | 1.04% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 1.44 M | $12.90 M | 144.16% | 1.03% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2026 | 1.25 M | $11.19 M | 1,403.35% | 0.90% |
| CLEARSTEAD ADVISORS, LLC | 05/06/2026 | 1.22 M | $10.90 M | 100.00% | 0.87% |
| 05/14/2026 | 1.20 M | $10.74 M | 100.00% | 0.86% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 1.17 M | $10.50 M | 29.54% | 0.84% |
| CANDRIAM S.C.A. | 04/30/2026 | 1.14 M | $10.18 M | 10.09% | 0.82% |
| JPMORGAN CHASE & CO | 05/13/2026 | 1.12 M | $9.45 M | 166.96% | 0.80% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 1.08 M | $9.66 M | 285.45% | 0.77% |
| ENSIGN PEAK ADVISORS, INC | 05/13/2026 | 1.07 M | $9.59 M | 101.50% | 0.77% |
| NUVEEN, LLC | 04/30/2026 | 1.02 M | $9.13 M | 80.17% | 0.73% |
| NORTHERN TRUST CORP | 05/14/2026 | 985.44 K | $8.83 M | 16.14% | 0.71% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 965.81 K | $8.65 M | 3.75% | 0.69% |
| AVIDITY PARTNERS MANAGEMENT LP | 05/28/2026 | 950.00 K | $8.51 M | 100.00% | 0.68% |
| D. E. SHAW & CO., INC. | 05/15/2026 | 817.69 K | $7.33 M | 1,542.20% | 0.59% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 761.36 K | $6.82 M | 23.91% | 0.55% |
| UBS GROUP AG | 05/05/2026 | 744.14 K | $6.67 M | 78.04% | 0.53% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 731.72 K | $6.56 M | 100.00% | 0.53% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 05/14/2026 | 730.55 K | $6.55 M | 100.00% | 0.52% |
| WALLEYE CAPITAL LLC | 05/13/2026 | 665.58 K | $5.96 M | 159.87% | 0.48% |
| BANK OF NEW YORK MELLON CORP | 05/05/2026 | 584.05 K | $5.23 M | 7.06% | 0.42% |
| NORDEA INVESTMENT MANAGEMENT AB | 05/13/2026 | 580.76 K | $5.09 M | -4.75% | 0.42% |
| AQR CAPITAL MANAGEMENT LLC | 05/15/2026 | 566.01 K | $5.07 M | 203.78% | 0.41% |
| PRINCIPAL FINANCIAL GROUP INC | 05/04/2026 | 547.75 K | $4.91 M | 21.56% | 0.39% |
| EMPYREAN CAPITAL PARTNERS, LP | 05/15/2026 | 527.80 K | $4.73 M | 100.00% | 0.38% |
| ALTA PARTNERS MANAGEMENT COMPANY, L.P. | 04/21/2026 | 509.92 K | $4.57 M | 0.00% | 0.37% |
| PARKMAN HEALTHCARE PARTNERS LLC | 05/15/2026 | 500.00 K | $4.48 M | 100.00% | 0.36% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 489.36 K | $4.38 M | -51.19% | 0.35% |
| ALGERT GLOBAL LLC | 05/14/2026 | 489.01 K | $4.38 M | 100.00% | 0.35% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Vir Biotechnology Inc institutional Ownership - FAQ's
During the previous two years, 317 institutional investors and hedge funds held shares of Vir Biotechnology Inc. The most heavily invested institutionals were:
BlackRock, Inc.: 18 M
ARCH Venture Management, LLC: 12.92 M
SB INVESTMENT ADVISERS (UK) LTD: 10.95 M
GSK PLC: 8.55 M
STATE STREET CORP: 7.14 M
GOLDMAN SACHS GROUP INC: 3.25 M
100.18% of Vir Biotechnology Inc stock is owned by institutional investors.
Institutional investors have bought a total of 155.09 M shares in the last 24 months. This purchase volume represents approximately $1.52 B in transactions.